This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

A Speculative Biotech Catalyst Trade: ORMP

The third reason I like ORMP here from a trading perspective is because the stock is heavily shorted. The current short interest as a percentage of the float from ORMP is pretty high at 11.6%. According to the most recent data, ORMP has a tradable float of 7.63 million shares and 886,000 of those shares are sold short by the bears. This is the type of situation that's begging for a squeeze since we have a significant catalyst that's less than a month away.

>>Beat the S&P in 2014 With the Stocks Everyone Else Hates

The final reason I like ORMP from a trading standpoint here is because a major shareholder just bought 75,000 shares, or above $796,000 worth of stock, at $10.62 per share. This same beneficial owner, Regals Capital Management, also bought 51,000 shares, or about $800,000 worth of stock, at $14.96 per share in early February. A major holder of ORMP shares is in the market buying stock right now -- that should be enough to make any trader take notice.

All things considered, this is a situation that could produce a monster short squeeze as the catalyst for ORMP gets closer. Remember, this is a trading opportunity I am highlighting here -- nothing more and nothing less -- but it's an opportunity that I think could potentially bank big dollars if ORMP can start to trend in the right direction and soon.

From a technical perspective, this stock has started to find support right around its intraday low from its previous gap-up-day zone from last December that took the stock from $6.83 to almost $14 a share. Shares of ORMP are bouncing sideways here right above the 200-day moving average, and the stock is starting to trend within range of triggering a major breakout trade. That trade will hit if ORMP manages to take out some near-term overhead resistance levels at $11.80 to $12 a share and then $12.50 a share with high volume Look for volume on that move that hits near or above its three-month average action of 734,136 shares.

Traders can look to buy ORMP off weakness as long as it's trending above its 200-day moving average at $10.25 or above its recent low of $9.64, or look to buy it off strength once it clears those breakout levels with strong volume. Keep in mind that I would want nothing to do with this stock from the long side if it broke below $9.64 with volume, since then the risk would be that ORMP could fill the gap that started at $6.83 last December.

If this stock does break out soon, then it could easily squeeze big and tag $14 to $15 a share or even $16 to $18 a share. The upper end of these targets would not be hard to hit, considering how oversold and heavily shorted ORMP is, so keep this name on your trading radar.

-- Written by Roberto Pedone in Delafield, Wis.

RELATED LINKS:

 

 

 

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs